Light Mode
$3.42 ↑ +0.00 (+0.00%) Trading Up from the previous close of $3.42, $0.32 below the day’s high of $3.74
-4.13 (-54.70%) / 6M
Momentum, market sentiment, and recent alerts
ACET reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +338.8%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf†gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.